GEN Exclusives

More »

GEN News Highlights

More »
Feb 20, 2007

Entelos and Organon Renew Rheumatoid Arthritis Research Agreement

  • Entelos and Organon extended their ongoing rheumatoid arthritis collaboration.

    “Organon was one of the first companies to recognize the potential impact of Entelos’ biosimulation capability and therapeutic expertise,” states James Karis, president and CEO of Entelos. 

    In silico R&D is a predictive research method aimed at increasing efficiency and productivity across the entire drug discovery and development pipeline. Using virtual patients and virtual drugs and targets, experiments are simulated, rapidly testing what would otherwise take months or years to do in the laboratory or clinic.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »